TA
COLL icon

Tamarack Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Tamarack Advisers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-185,000
Closed -$4.13M – 7
2023
Q3 		$4.13M Sell
185,000
-190,000
-51% -$4.33M 2.68% 11
2023
Q2 		$8.06M Buy
375,000
+20,000
+6% +$454K 2.49% 6
2023
Q1 		$8.52M Sell
355,000
-32,000
-8% -$849K 3.11% 8
2022
Q4 		$8.98M Buy
387,000
+87,000
+29% +$1.75M 4.62% 7
2022
Q3 		$4.81M Buy
300,000
+200,000
+200% +$3.53M 2.82% 16
2022
Q2 		$1.77M Buy
+100,000
New +$1.68M 1.03% 25
2016
Q3 		– Sell
-94,908
Closed -$1.13M – 39
2016
Q2 		$1.13M Buy
+94,908
New +$1.57M 0.43% 26

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return